Takeda Reports First Quarter FY2018 Results

OSAKA, Japan–(BUSINESS WIRE)–Jul 31, 2018–Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth +6.4% with growth in every region Underlying Revenue grew +6.4%, led by Taked…
( read original story …)